We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

GlaxoSmithKline Royalties Come Under Scrutiny

Law360 (September 20, 2006, 12:00 AM EDT) -- Massachusetts-based biopharmaceutical company Avant Immunotherapeutics Inc. said on Wednesday that GlaxoSmithKline has been paying the lower of two royalty rates on its sales for a rotavirus vaccine in Australia and several...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.